(Total Views: 580)
Posted On: 01/26/2020 6:24:47 PM
Post# of 72445
I'm still wondering whether the Novartis - BDD license with the words "undisclosed compound" may have to do with a drug currently owned by another company "Brilacidin owned by IPIX".
Do Novartis and IPIX have a CDA in place that would denote the product as an "undisclosed compound". And with an undisclosed compound agreement and use of Oralogik, Novartis would
be granted the First Right to Negotiate a deal for Bril-UC after Phase 1??
Do Novartis and IPIX have a CDA in place that would denote the product as an "undisclosed compound". And with an undisclosed compound agreement and use of Oralogik, Novartis would
be granted the First Right to Negotiate a deal for Bril-UC after Phase 1??
(3)
(1)
